SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas is participating in a health reform panel discussion for the Capitolbeat Annual Conference in Indianapolis, IN
News | 08. 21. 2009
